Clinical trials recruiting for Malignancy

Phase breakdown

Drugs and treatments being studied

Self-screener

Recruiting trials

• Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor
  NCT05761366 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
  NCT05770102 · Phase: Phase 2, Phase 3 · Ages: No age limits stated · Sex: All (male and female) · 54 locations
• DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
  NCT05770544 · Phase: Phase 2, Phase 3 · Ages: No age limits stated · Sex: All (male and female) · 27 locations
• Target-specific immunoPET Imaging of Digestive System Carcinoma
  NCT06715839 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations

Related conditions

Trials recruiting for Malignancy often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Malignancy trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.